Prevention of COPD exacerbations: medications and other controversies
Exacerbations have significant impact on the morbidity and mortality of patients with chronic obstructive pulmonary disease. Most guidelines emphasise prevention of exacerbations by treatment with long-acting bronchodilators and/or anti-inflammatory drugs. Whereas most of this treatment is evidence-...
Main Authors: | Jørgen Vestbo, Peter Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2015-05-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/1/1/00011-2015.full |
Similar Items
-
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
by: Alexander G. Mathioudakis, et al.
Published: (2019-11-01) -
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
by: Alexander G. Mathioudakis, et al.
Published: (2017-02-01) -
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
by: Alexander G. Mathioudakis, et al.
Published: (2019-05-01) -
Benralizumab for the prevention of COPD exacerbations
by: Criner, G, et al.
Published: (2019) -
Cardiovascular predictors of mortality and exacerbations in patients with COPD
by: Peter Alter, et al.
Published: (2022-12-01)